Mehdi Layeghifard

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Nature communications

Nature cancer

Science (New York, N.Y.)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N Hayes, Meredith S Irwin
SHP2 inhibition with TNO155 increases efficacy and overcomes resistance of ALK inhibitors in neuroblastoma. Cancer research communications (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Nathaniel D Anderson, Yael Babichev, Fabio Fuligni, Federico Comitani, Mehdi Layeghifard, Rosemarie E Venier, Stefan C Dentro, Anant Maheshwari, Sheena Guram, Claire Wunker, J Drew Thompson, Kyoko E Yuki, Huayun Hou, Matthew Zatzman, Nicholas Light, Marcus Q Bernardini, Jay S Wunder, Irene L Andrulis, Peter Ferguson, Albiruni R Abdul Razak, Carol J Swallow, James J Dowling, Rima S Al-Awar, Richard Marcellus, Marjan Rouzbahman, Moritz Gerstung, Daniel Durocher, Ludmil B Alexandrov, Brendan C Dickson, Rebecca A Gladdy, Adam Shlien
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival. Nature communications 12 (1) (2021)
Nathaniel D Anderson, Richard J de Borja, Matthew D Young, Fabio Fuligni, Andrej Rosic, Nicola D Roberts, Simon Hajjar, Mehdi Layeghifard, Ana Novokmet, Paul E Kowalski, Matthew Anaka, Scott Davidson, Mehdi Zarrei, Badr Id Said, L Christine Schreiner, Remi Marchand, Joseph Sitter, Nalan Gokgoz, Ledia Brunga, Garrett T Graham, Anthony Fullam, Nischalan Pillay, Jeffrey A Toretsky, Akihiko Yoshida, Tatsuhiro Shibata, Markus Metzler, Gino R Somers, Stephen W Scherer, Adrienne M Flanagan, Peter J Campbell, Joshua D Schiffman, Mary Shago, Ludmil B Alexandrov, Jay S Wunder, Irene L Andrulis, David Malkin, Sam Behjati, Adam Shlien
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science (New York, N.Y.) 361 (6405) (2018)

Mehdi Layeghifard.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mehdi Layeghifard